George Breen and Robert Wanerman, Members of the Firm, speak at the American Health Law Association (AHLA) Institute on Medicare and Medicaid Payment Issues, which runs from March 18 to 20.
George co-presents "Legal Ethics: AI in Litigation and Government Investigations – Ethical Duties in an Algorithmic Era" on March 18 (1:15 p.m.) and again on March 20 (10:45 a.m.). Topics include:
- Artificial intelligence is now embedded in litigations and internal investigations. When lawyers rely on AI tools in litigation, to detect overpayments, prioritize risk, summarize subpoenaed materials, respond to Courts, opposing counsel or regulators, professional responsibility obligations are directly implicated.
- How AI-assisted workflows intersect with duties of competence, supervision, independent judgment, confidentiality, candor to the Court and truthfulness. Using hypotheticals, the panel will explore when reliance on algorithmic outputs becomes ethically problematic – what the expectations are and how lawyers can structure defensible oversight in high-risk matters.
Rob co-presents "Generating Revenue During Clinical Trials: Medicare and Medicaid Coverage of Clinical Trial Costs" on March 19 (2:45 p.m.). Topics include:
- Medicare and Medicaid coverage of clinical trial costs.
- Special rules for submitting reimbursement claims.
- Compliance safeguards and understanding enforcement actions.
- How to leverage your FDA IDE clinical study for pre-market Medicare coverage.
- Identifying which studies qualify for FDA's Category A vs. B – and why it matters.
- Harmonizing FDA and CMS' divergent requirements in a unified protocol.
- Designing your IDE to support downstream market access and commercialization.
- Bonus material: Avoiding common CMS IDE pitfalls and positioning your submission for first-cycle CMS approval.
For more information, visit the event website.
Event Detail
Baltimore, MD